Differential responses to 223Ra and Alpha-particles exposure in prostate cancer driven by mitotic catastrophe

IntroductionRadium-223 (223Ra) has been shown to have an overall survival benefit in metastatic castration-resistant prostate cancer (mCRPC) involving bone. Despite its increased clinical usage, relatively little is known regarding the mechanism of action of 223Ra at the cellular level.MethodsWe eva...

Full description

Bibliographic Details
Main Authors: Francisco D. C. Guerra Liberal, Hugo Moreira, Kelly M. Redmond, Joe M. O’Sullivan, Ali H. D. Alshehri, Timothy C. Wright, Victoria L. Dunne, Caoimhghin Campfield, Sandra Biggart, Stephen J. McMahon, Kevin M. Prise
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.877302/full
_version_ 1818002038462611456
author Francisco D. C. Guerra Liberal
Hugo Moreira
Kelly M. Redmond
Joe M. O’Sullivan
Joe M. O’Sullivan
Ali H. D. Alshehri
Ali H. D. Alshehri
Timothy C. Wright
Victoria L. Dunne
Caoimhghin Campfield
Sandra Biggart
Stephen J. McMahon
Kevin M. Prise
author_facet Francisco D. C. Guerra Liberal
Hugo Moreira
Kelly M. Redmond
Joe M. O’Sullivan
Joe M. O’Sullivan
Ali H. D. Alshehri
Ali H. D. Alshehri
Timothy C. Wright
Victoria L. Dunne
Caoimhghin Campfield
Sandra Biggart
Stephen J. McMahon
Kevin M. Prise
author_sort Francisco D. C. Guerra Liberal
collection DOAJ
description IntroductionRadium-223 (223Ra) has been shown to have an overall survival benefit in metastatic castration-resistant prostate cancer (mCRPC) involving bone. Despite its increased clinical usage, relatively little is known regarding the mechanism of action of 223Ra at the cellular level.MethodsWe evaluated the effects of 223Ra irradiation in a panel of cell lines and then compared them with standard X-ray and external alpha-particle irradiation, with a particular focus on cell survival and DNA damage repair kinetics.Results223Ra exposures had very high, cell-type-dependent RBE50% ranging from 7 to 15. This was significantly greater than external alpha irradiations (RBE50% from 1.4 to 2.1). These differences were shown to be partially related to the volume of 223Ra solution added, independent of the alpha-particle dose rate, suggesting a radiation-independent mechanism of effect. Both external alpha particles and 223Ra exposure were associated with delayed DNA repair, with similar kinetics. Additionally, the greater treatment efficacy of 223Ra was associated with increased levels of residual DNA damage and cell death by mitotic catastrophe.ConclusionsThese results suggest that 223Ra exposure may be associated with greater biological effects than would be expected by direct comparison with a similar dose of external alpha particles, highlighting important challenges for future therapeutic optimization.
first_indexed 2024-04-14T03:41:41Z
format Article
id doaj.art-c036d2a956814f3e95393de65eb7ca6f
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-14T03:41:41Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-c036d2a956814f3e95393de65eb7ca6f2022-12-22T02:14:31ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-07-011210.3389/fonc.2022.877302877302Differential responses to 223Ra and Alpha-particles exposure in prostate cancer driven by mitotic catastropheFrancisco D. C. Guerra Liberal0Hugo Moreira1Kelly M. Redmond2Joe M. O’Sullivan3Joe M. O’Sullivan4Ali H. D. Alshehri5Ali H. D. Alshehri6Timothy C. Wright7Victoria L. Dunne8Caoimhghin Campfield9Sandra Biggart10Stephen J. McMahon11Kevin M. Prise12The Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, United KingdomThe Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, United KingdomThe Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, United KingdomThe Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, United KingdomNorthern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, United KingdomThe Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, United KingdomDepartment of Radiological Sciences, College of Applied Medical Sciences, Najran University, Najran, Saudi ArabiaThe Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, United KingdomThe Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, United KingdomNorthern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, United KingdomNorthern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, United KingdomThe Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, United KingdomThe Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, United KingdomIntroductionRadium-223 (223Ra) has been shown to have an overall survival benefit in metastatic castration-resistant prostate cancer (mCRPC) involving bone. Despite its increased clinical usage, relatively little is known regarding the mechanism of action of 223Ra at the cellular level.MethodsWe evaluated the effects of 223Ra irradiation in a panel of cell lines and then compared them with standard X-ray and external alpha-particle irradiation, with a particular focus on cell survival and DNA damage repair kinetics.Results223Ra exposures had very high, cell-type-dependent RBE50% ranging from 7 to 15. This was significantly greater than external alpha irradiations (RBE50% from 1.4 to 2.1). These differences were shown to be partially related to the volume of 223Ra solution added, independent of the alpha-particle dose rate, suggesting a radiation-independent mechanism of effect. Both external alpha particles and 223Ra exposure were associated with delayed DNA repair, with similar kinetics. Additionally, the greater treatment efficacy of 223Ra was associated with increased levels of residual DNA damage and cell death by mitotic catastrophe.ConclusionsThese results suggest that 223Ra exposure may be associated with greater biological effects than would be expected by direct comparison with a similar dose of external alpha particles, highlighting important challenges for future therapeutic optimization.https://www.frontiersin.org/articles/10.3389/fonc.2022.877302/fullalpha particlesradium-223mitotic catastropheradiation effectsbone metastases
spellingShingle Francisco D. C. Guerra Liberal
Hugo Moreira
Kelly M. Redmond
Joe M. O’Sullivan
Joe M. O’Sullivan
Ali H. D. Alshehri
Ali H. D. Alshehri
Timothy C. Wright
Victoria L. Dunne
Caoimhghin Campfield
Sandra Biggart
Stephen J. McMahon
Kevin M. Prise
Differential responses to 223Ra and Alpha-particles exposure in prostate cancer driven by mitotic catastrophe
Frontiers in Oncology
alpha particles
radium-223
mitotic catastrophe
radiation effects
bone metastases
title Differential responses to 223Ra and Alpha-particles exposure in prostate cancer driven by mitotic catastrophe
title_full Differential responses to 223Ra and Alpha-particles exposure in prostate cancer driven by mitotic catastrophe
title_fullStr Differential responses to 223Ra and Alpha-particles exposure in prostate cancer driven by mitotic catastrophe
title_full_unstemmed Differential responses to 223Ra and Alpha-particles exposure in prostate cancer driven by mitotic catastrophe
title_short Differential responses to 223Ra and Alpha-particles exposure in prostate cancer driven by mitotic catastrophe
title_sort differential responses to 223ra and alpha particles exposure in prostate cancer driven by mitotic catastrophe
topic alpha particles
radium-223
mitotic catastrophe
radiation effects
bone metastases
url https://www.frontiersin.org/articles/10.3389/fonc.2022.877302/full
work_keys_str_mv AT franciscodcguerraliberal differentialresponsesto223raandalphaparticlesexposureinprostatecancerdrivenbymitoticcatastrophe
AT hugomoreira differentialresponsesto223raandalphaparticlesexposureinprostatecancerdrivenbymitoticcatastrophe
AT kellymredmond differentialresponsesto223raandalphaparticlesexposureinprostatecancerdrivenbymitoticcatastrophe
AT joemosullivan differentialresponsesto223raandalphaparticlesexposureinprostatecancerdrivenbymitoticcatastrophe
AT joemosullivan differentialresponsesto223raandalphaparticlesexposureinprostatecancerdrivenbymitoticcatastrophe
AT alihdalshehri differentialresponsesto223raandalphaparticlesexposureinprostatecancerdrivenbymitoticcatastrophe
AT alihdalshehri differentialresponsesto223raandalphaparticlesexposureinprostatecancerdrivenbymitoticcatastrophe
AT timothycwright differentialresponsesto223raandalphaparticlesexposureinprostatecancerdrivenbymitoticcatastrophe
AT victorialdunne differentialresponsesto223raandalphaparticlesexposureinprostatecancerdrivenbymitoticcatastrophe
AT caoimhghincampfield differentialresponsesto223raandalphaparticlesexposureinprostatecancerdrivenbymitoticcatastrophe
AT sandrabiggart differentialresponsesto223raandalphaparticlesexposureinprostatecancerdrivenbymitoticcatastrophe
AT stephenjmcmahon differentialresponsesto223raandalphaparticlesexposureinprostatecancerdrivenbymitoticcatastrophe
AT kevinmprise differentialresponsesto223raandalphaparticlesexposureinprostatecancerdrivenbymitoticcatastrophe